These findings suggest that clinicians should thoroughly consider immune-compromising factors when managing fungal infections in patients without HIV/AIDS, especially when IgE levels are elevated, suggesting the possibility of immunodeficiency. The gene discussed is IGHE; the disease is immunodeficiency disease.